Catatonia: Difference between revisions
| Line 14: | Line 14: | ||
==Management== | ==Management== | ||
*"Benzodiazepine challenge" (first-line treatment) | |||
**Lorazepam IV 2mg; repeat prn | |||
**60-70% of patients will achieve remission with benzodiazepine monotherapy<ref>Luchini F, Medda P, Mariani MG, Mauri M, Toni C, Perugi G. Electroconvulsive therapy in catatonic patients: Efficacy and predictors of response. World J Psychiatry. 2015;5(2):182-192. doi:10.5498/wjp.v5.i2.182</ref> | |||
*Second line treatment is electro-convulsive therapy (ECT) | |||
**80-100% effective | |||
==Disposition== | ==Disposition== | ||
Revision as of 01:54, 7 September 2021
Background
- Catatonia is a syndrome characterized by psychomotor abnormalities, often presenting as a state of apparent unresponsiveness to external stimuli or inability to move normally in a person who is awake[1]
Clinical Features
Differential Diagnosis
Evaluation
Workup
Diagnosis
Management
- "Benzodiazepine challenge" (first-line treatment)
- Lorazepam IV 2mg; repeat prn
- 60-70% of patients will achieve remission with benzodiazepine monotherapy[2]
- Second line treatment is electro-convulsive therapy (ECT)
- 80-100% effective
Disposition
See Also
External Links
References
- ↑ Fink M. The catatonia syndrome: forgotten but not gone. Arch Gen Psychiatry. 2009. 66:1173
- ↑ Luchini F, Medda P, Mariani MG, Mauri M, Toni C, Perugi G. Electroconvulsive therapy in catatonic patients: Efficacy and predictors of response. World J Psychiatry. 2015;5(2):182-192. doi:10.5498/wjp.v5.i2.182